These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38306823)

  • 21. [A case of primary breast cancer who responded remarkably to the neoadjuvant chemotherapy with the combination of docetaxel and cyclophosphamide].
    Yoshibayashi H; Ishiguro H; Takada M; Takeuchi M; Yamashiro H; Ueno T; Kato H; Yoshikawa K; Kanao S; Yamauchi C; Mikami Y; Toi M
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):987-90. PubMed ID: 18633230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A Case Performed Mastectomy to Tumor Progression of Breast Cancer Omitting Surgery after Neoadjuvant Chemotherapy].
    Hojo S; Yoshioka S; Wakabayashi Y
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1594-1596. PubMed ID: 36733146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of refractory metastatic anal squamous cell carcinoma following disease progression on traditional chemoradiation therapy.
    Silva NN; Eng C
    J Adv Pract Oncol; 2012 May; 3(3):161-9. PubMed ID: 25031942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current and Emerging Therapies for HER2-Positive Women With Metastatic Breast Cancer.
    Porter K; Rosenzweig MQ
    J Adv Pract Oncol; 2017 Mar; 8(2):164-168. PubMed ID: 29900024
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of Pregnancy-Associated Breast Cancer.
    Labriola B
    J Adv Pract Oncol; 2019; 10(7):692-700. PubMed ID: 33391853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute inflammatory response to multiple chemotherapy regimen in breast carcinoma: An unreported entity1.
    Jha CK; Verma H; Sinha U; Singh PK
    Breast Dis; 2022; 41(1):391-395. PubMed ID: 36442188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-Phenotypic Breast Cancer Post-Radiotherapy for Hodgkin Lymphoma: A Case of Secondary Malignancy.
    White D; Sadough Shahmirzadi M; Boulmay B
    J Investig Med High Impact Case Rep; 2023; 11():23247096231188251. PubMed ID: 37480256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of quadruple primary malignancies including breast, tongue, and thyroid cancers and osteosarcoma in a young female without karyotype abnormality.
    Kousaka J; Fujii K; Yorozuya K; Mouri Y; Yoshida M; Nakano S; Fukutomi T; Takahashi E; Yokoi T
    Breast Cancer; 2014 Jul; 21(4):500-3. PubMed ID: 21562838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histology.
    Moran MS; Yang Q; Haffty BG
    Breast J; 2009; 15(6):571-8. PubMed ID: 19995377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis.
    Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
    Cancer Med; 2017 Dec; 6(12):2775-2786. PubMed ID: 29072365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma.
    Cocquyt VF; Blondeel PN; Depypere HT; Praet MM; Schelfhout VR; Silva OE; Hurley J; Serreyn RF; Daems KK; Van Belle SJ
    Eur J Surg Oncol; 2003 May; 29(4):361-7. PubMed ID: 12711290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Change of Pathological Type to Metaplastic Squamous Cell Carcinoma of the Breast During Disease Recurrence: Case Report and Literature Review.
    Guo T; Chen Z; Xu J; Zhang Y
    Front Oncol; 2020; 10():32. PubMed ID: 32161717
    [No Abstract]   [Full Text] [Related]  

  • 34. Responding to the challenges of breast cancer in egypt and other arab countries.
    El Saghir NS
    J Egypt Natl Canc Inst; 2008 Dec; 20(4):309-12. PubMed ID: 20571588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salivary Duct Carcinoma and Invasive Ductal Carcinoma of the Breast: A Comparative Immunohistochemical Study.
    Jalaly JB; Sanati S; Chernock RD; Dibe DG; El-Mofty SK
    Head Neck Pathol; 2018 Dec; 12(4):488-492. PubMed ID: 29302899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
    Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM
    Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invasive Ductal Carcinoma Breast: How Neoadjuvant Chemotherapy Affects the Status of Estrogen Receptor, Progesterone Receptor and HER2/Neu-A Tertiary Care Centre Study.
    Shubham S; Maan P; Singh M; Bhardwaj M
    J Clin Diagn Res; 2017 Jul; 11(7):EC06-EC08. PubMed ID: 28892901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herbo-mineral ayurvedic treatment in a high risk acute promyelocytic leukemia patient with second relapse: 12 years follow up.
    Prakash B; Parikh PM; Pal SK
    J Ayurveda Integr Med; 2010 Jul; 1(3):215-8. PubMed ID: 21547051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].
    Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1301-3. PubMed ID: 16969029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.